Document:

Exhibit 10.28

 

EXECUTIVE
Employment Agreement

 

This Executive
Employment Agreement dated as of February 18, 2016  (“Agreement”) is by and between
Lawrence A. Kenyon (“Executive”) and Oncobiologics,
Inc. (“Company”).

 

Whereas,
Executive has been employed by the Company as its Chief Financial Officer and Secretary pursuant to a letter agreement with the
Company dated August 30, 2015 (the “Prior Agreement”), and the Company desires to continue the employment
of Executive as its Chief Financial Officer and Secretary and provide Executive with certain compensation and benefits in return
for Executive’s services, and Executive agrees to be retained by the Company in such capacity and to receive the compensation
and benefits on the terms and conditions set forth herein; and

 

Whereas,
the Company and Executive desire to enter into this Employment Agreement (the “Agreement”) to become
effective and replace and supersede the Prior Agreement, subject to Executive’s signature below, upon the date of the underwriting
agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock,
pursuant to which such common stock is priced for the initial public offering (the “Effective Date”)
in order to memorialize the terms and conditions of Executive’s employment by the Company upon and following the Effective
Date.

 

Now,
Therefore, in consideration of the mutual promises and covenants contained herein, the parties agree to the following:

 

		1.	Employment by the Company.

 

1.1           Position.  Subject
to the terms set forth herein, the Company agrees to continue to employ Executive in the position of Chief Financial Officer
and Secretary, and Executive hereby accepts such continued employment on the terms and conditions set forth in this Agreement.

 

1.2           Duties.  As
Chief Financial Officer and Secretary, Executive will report to the Chief Executive Officer (“CEO”) and/or
such executive designated by the CEO, performing such duties as are normally associated with his position and such duties as are
assigned to him from time to time, subject to the oversight and direction of the CEO or his designee.  During the term
of Executive’s employment with the Company, Executive will work on a full-time basis for the Company and will devote Executive’s
best efforts and substantially all of Executive’s business time and attention to the business of the Company.  Executive
shall perform Executive’s duties under this Agreement principally out of the Company’s facility in Cranbury, New Jersey.  In
addition, Executive shall make such business trips to such places as may be necessary or advisable for the efficient operations
of the Company.

 

1.3           Company
Policies and Benefits.  The employment relationship between the parties shall also be subject to the Company’s
personnel policies and procedures as they may be interpreted, adopted, revised or deleted from time to time in the Company’s
sole discretion.  Executive will be eligible to participate on the same basis as similarly situated employees in the

 

    	 	1.	 

     

    

 

Company’s benefit
plans in effect from time to time during his employment.  All matters of eligibility for coverage or benefits under any
benefit plan shall be determined in accordance with the provisions of such plan.  The Company reserves the right to change,
alter, or terminate any benefit plan in its sole discretion.  Notwithstanding the foregoing, in the event that the terms
of this Agreement differ from or are in conflict with the Company’s general employment policies or practices, this Agreement
shall control.  

 

1.4           Vacation.  While
this Agreement is in effect, Executive shall also receive three (3) weeks of vacation per full calendar year (prorated for any
partial calendar year of employment) subject to the Company’s vacation policies and procedures as in effect or amended from
time to time, which vacation time shall accrue pro-rata on a pay period basis. Executive may not carryover any earned but unused
vacation time from any calendar year to any subsequent calendar year unless otherwise expressly required by applicable law or permitted
by applicable Company policies.  

 

		2.	Compensation.

 

2.1           Salary.  Executive
shall receive for Executive’s services to be rendered under this Agreement an initial base salary of $350,000 on an annualized
basis, subject to review and adjustment by the Company in its sole discretion, payable subject to standard federal and state payroll
withholding requirements in accordance with the Company’s standard payroll practices (“Base Salary”).

 

2.2           Annual
Bonus. While this Agreement is in effect, Executive shall be eligible for a discretionary annual cash bonus of a target amount
equal to 40% of Base Salary (“Target Amount”), subject to review and adjustment by the Company in its
sole discretion, payable subject to standard federal and state payroll withholding requirements.  Whether or not Executive
earns any bonus will be dependent upon (a) Executive’s continuous performance of services to the Company through the date
any bonus is paid; and (b) the actual achievement by Executive and the Company of the applicable performance targets and goals
set by the Board of Directors of the Company (the “Board”) or its Compensation Committee.  The
annual period over which performance is measured for purposes of this bonus is January 1 through December 31.  The Board
or its Compensation Committee will determine in its sole discretion the extent to which Executive and the Company have achieved
the performance goals upon which the bonus is based and the amount of the bonus, which could be below the Target Amount (and may
be zero).  The bonus, if awarded, will be paid no later than March 15 of the calendar year immediately following the
calendar year for which the bonus is being measured.

 

2.3           Equity.
Executive was previously granted 150,000 restricted stock units (the “RSUs”).  The RSUs are
governed by the relevant equity plan(s) and/or award agreement(s), unless specifically stated otherwise in this Agreement.

 

2.4           Expense
Reimbursement.  The Company will reimburse Executive for reasonable business expenses in accordance with the Company’s
standard expense reimbursement policy, as the same may be modified by the Company from time to time.  The Company shall
reimburse Executive for all customary and appropriate business-related expenses actually incurred and documented in accordance
with Company policy, as in effect from time to

 

    	 	2.	 

     

    

 

time.  For
the avoidance of doubt, to the extent that any reimbursements payable to Executive are subject to the provisions of Section 409A
of the Code:  (a) any such reimbursements will be paid no later than December 31 of the year following the year in which
the expense was incurred, (b) the amount of expenses reimbursed in one year will not affect the amount eligible for reimbursement
in any subsequent year, and (c) the right to reimbursement under this Agreement will not be subject to liquidation or exchange
for another benefit.

 

3.            Proprietary
Information, Inventions, Non-Competition and Non-Solicitation Obligations.    As
a condition of continued employment, Executive agrees to execute and abide by an Employee Proprietary Information, Inventions,
Non-Competition and Non-Solicitation Agreement attached as Exhibit A (“Proprietary Information Agreement”),
which may be amended by the parties from time to time without regard to this Agreement.  The Proprietary Information
Agreement contains provisions that are intended by the parties to survive and do survive termination of this Agreement.

 

4.            Outside
Activities during Employment.  Except with the prior written consent of the Board, including consent given to Executive
prior to the signing of this Agreement, Executive will not, while employed by the Company, undertake or engage in any other employment,
occupation or business enterprise that would interfere with Executive’s responsibilities and the performance of Executive’s
duties hereunder except for (i) reasonable time devoted to volunteer services for or on behalf of such religious, educational,
non-profit and/or other charitable organization as Executive may wish to serve, (ii) reasonable time devoted to activities in the
non-profit and business communities consistent with Executive’s duties; and (iii) such other activities as may be specifically
approved by the Board. This restriction shall not, however, preclude Executive (x) from owning less than one percent (1%) of the
total outstanding shares of a publicly traded company, or (y) from employment or service in any capacity with Affiliates of the
Company.  As used in this Agreement, “Affiliates” means an entity under common management or
control with the Company.

 

5.            No
Conflict with Existing Obligations.  Executive represents that Executive’s performance of all the terms of
this Agreement does not and will not breach any agreement or obligation of any kind made prior to Executive’s employment
by the Company, including agreements or obligations Executive may have with prior employers or entities for which Executive has
provided services.  Executive has not entered into, and Executive agrees that Executive will not enter into, any agreement
or obligation, either written or oral, in conflict herewith.

 

6.            Termination
of Employment.  The parties acknowledge that Executive’s employment relationship with the Company is at-will,
meaning either the Company or Executive may terminate Executive’s employment at any time, with or without cause or advance
notice.  The provisions in this Section govern the amount of compensation, if any, to be provided to Executive upon termination
of employment and do not alter this at-will status.

 

		6.1	Termination by the Company without Cause or for
Good Reason.

 

(a)          The
Company shall have the right to terminate Executive’s employment with the Company pursuant to this Section 6.1 at
any time, in accordance with

 

    	 	3.	 

     

    

 

Section 6.6, without
“Cause” (as defined in Section 6.3(b) below) by giving notice as described in Section 7.1 of this Agreement.  A
termination pursuant to Section 6.5 below is not a termination without “Cause” for purposes of receiving the
benefits described in Sections 6.1 or Section 6.2.

 

(b)          If
the Company terminates Executive’s employment at any time without Cause or Executive terminates his employment with the Company
for Good Reason and provided that such termination constitutes a “separation from service” (as defined under Treasury
Regulation Section 1.409A-1(h), without regard to any alternative definition thereunder, a “Separation from Service”),
then Executive shall be entitled to receive the Accrued Obligations (defined below).  If Executive complies with the
obligations in Section 6.1(c) below, Executive shall also be eligible to receive the following “Severance Benefits”:

 

(i)          The
Company will pay Executive an amount equal to Executive’s then current Base Salary for twelve (12) months, less all applicable
withholdings and deductions, paid in equal installments on the Company’s normal payroll schedule following the termination
date, with the first payment beginning on the Severance Pay Commencement Date (as defined in Section 6.1(c) below), and
the remaining installments occurring on the Company’s regularly scheduled payroll dates thereafter; provided that on the
Severance Pay Commencement Date, the Company will pay in a lump sum the aggregate amount of the cash severance payments that the
Company would have paid Executive through such date had the payments commenced on the effective date of termination through the
Severance Pay Commencement Date.

 

(ii)         If
Executive timely elects continued coverage under COBRA for himself and his covered dependents under the Company’s group health
plans following such termination, then the Company shall pay the COBRA premiums necessary to continue Executive’s and his
covered dependents’ health insurance coverage in effect for himself (and his covered dependents) on the termination date
until the earliest of: (i) twelve (12) months following the termination date (the “COBRA Severance Period”);
(ii) the date when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment
or self-employment; or (iii) the date Executive ceases to be eligible for COBRA continuation coverage for any reason, including
plan termination (such period from the termination date through the earlier of (i)-(iii), (the “COBRA Payment Period”).  Notwithstanding
the foregoing, if at any time the Company determines that its payment of COBRA premiums on Executive’s behalf would result
in a violation of applicable law (including, but not limited to, the 2010 Patient Protection and Affordable Care Act, as amended
by the 2010 Health Care and Education Reconciliation Act), then in lieu of paying COBRA premiums pursuant to this Section, the
Company shall pay Executive on the last day of each remaining month of the COBRA Payment Period, a fully taxable cash payment equal
to the COBRA premium for such month, subject to applicable tax withholding (such amount, the “Special Severance Payment”),
for the remainder of the COBRA Payment Period.  Nothing in this Agreement shall deprive Executive of his rights under
COBRA or ERISA for benefits under plans and policies arising under his employment by the Company.

 

(iii)        Notwithstanding
the terms of any equity plan or award agreement to the contrary, the time-based vesting conditions applicable to fifty percent
(50%) of Executive’s stock options and/or other equity awards subject to time-based vesting requirements

 

    	 	4.	 

     

    

 

that are outstanding
and not vested as of Executive’s termination date shall accelerate and deemed to be satisfied as of the date of Executive’s
termination.  For the avoidance of doubt, the accelerated vesting provided under this Section 6.1(b)(iv) shall not apply
to any liquidity event or performance-based vesting conditions applicable to any of Executive’s outstanding stock options
or other equity awards as of the date of termination.

 

(c)            Executive
will be paid all of the Accrued Obligations on the Company’s first payroll date after Executive’s date of termination
from employment or earlier if required by law.  Executive shall receive the Severance Benefits pursuant to Section
6.1(b) or the Change in Control Severance Benefits (defined below) pursuant to 6.2(a) of this Agreement,
as applicable, if:  (i) Executive executes and does not revoke a separation agreement containing an effective, general
release of claims in favor of the Company and its affiliates and representatives, in a form acceptable to the Company (the “Release”)
and the Release is enforceable and effective as provided in the Release on or before the date that is the sixtieth (60th)
day following the effective date of termination (such 60th day, the “Severance Pay Commencement Date”);
(ii) he holds any other positions with the Company, he resigns such position(s) to be effective no later than the date of Executive’s
termination date (or such other date as requested by the Board); (iii) he returns all Company property; (iv) he complies with his
post-termination obligations under this Agreement and the Proprietary Information Agreement; and (v) he complies with the terms
of the Release, including without limitation any non-disparagement and confidentiality provisions contained in Release.  

 

(d)           For
purposes of this Agreement, “Accrued Obligations” are (i) Executive’s accrued but unpaid salary
through the date of termination, (ii) any unreimbursed business expenses incurred by Executive payable in accordance with the Company’s
standard expense reimbursement policies, and (iii) benefits owed to Executive under any qualified retirement plan or health and
welfare benefit plan in which Executive was a participant in accordance with applicable law and the provisions of such plan.

 

(e)            The
Severance Benefits provided to Executive pursuant to this Section 6.1 are in lieu of, and not in addition to, any benefits
to which Executive may otherwise be entitled under any Company severance plan, policy or program.

 

(f)            Any
damages caused by the termination of Executive’s employment without Cause would be difficult to ascertain; therefore, the
Severance Benefits for which Executive is eligible pursuant to Section 6.1(b) above in exchange for the Release is agreed
to by the parties as liquidated damages, to serve as full compensation, and not a penalty.

 

(g)           For
purposes of this Agreement, “Good Reason” shall mean the occurrence of any of the following events without Executive’s
consent: (i) a material reduction in Executive’s Base Salary of at least 25%; (ii) a material breach of this Agreement by
the Company; (iii) a material reduction in the Executive’s duties, authority and responsibilities relative to the Executive’s
duties, authority, and responsibilities in effect immediately prior to such reduction; or (iv) the relocation of Executive’s
principal place of employment, without Executive’s consent, in a manner that lengthens his one-way commute distance by fifty
(50) or more miles from his then-current principal place of employment immediately prior to such relocation; provided, however,
that, any such termination by Executive shall only be deemed for

 

    	 	5.	 

     

    

 

Good Reason pursuant
to this definition if: (1) Executive gives the Company written notice of his intent to terminate for Good Reason within thirty
(30) days following the first occurrence of the condition(s) that he believes constitute(s) Good Reason, which notice shall describe
such condition(s); (2) the Company fails to remedy such condition(s) within thirty (30) days following receipt of the written notice
(the “Cure Period”); and (3) Executive voluntarily terminates his employment within thirty (30) days
following the end of the Cure Period.

 

6.2          Termination
by the Company without Cause or for Good Reason Coincident with a Change in Control.

 

(a)            If
Executive’s employment by the Company is terminated by the Company or any successor entity without “Cause” (and
not due to Disability or death) or by Executive for Good Reason within two (2) months prior to or within twelve (12) months following
the effective date of a “Change in Control” (as defined in the Company’s 2015 Equity Incentive
Plan, as such plan may be amended from time to time), provided that such termination constitutes a Separation from Service, without
regard to any alternative definition thereunder, then in addition to paying or providing Executive with the Accrued Obligations
and subject to compliance with Section 6.1(c), the Company will provide the following “Change in Control Severance
Benefits”:  

 

(i)          The
Company will pay Executive an amount equal to Executive’s then current Base Salary for twelve (12) months, less all applicable
withholdings and deductions, paid in equal installments on the Company’s normal payroll schedule following the date of Separation
from Service, with the first payment beginning on the Severance Pay Commencement Date, and the remaining installments occurring
on the Company’s regularly scheduled payroll dates thereafter; provided that on the Severance Pay Commencement Date, the
Company will pay in a lump sum the aggregate amount of the cash severance payments that the Company would have paid Executive through
such date had the payments commenced on the effective date of termination through the Severance Pay Commencement Date.

 

(ii)         The
Company will pay a bonus equivalent to Executive’s Target Amount for the performance year in which Executive’s termination
occurs.  This bonus will be payable subject to standard federal and state payroll withholding requirements in a lump
sum payment on the Severance Pay Commencement Date.

 

(iii)        If
Executive timely elects continued coverage under COBRA for himself and his covered dependents under the Company’s group health
plans following such termination, then the Company shall pay the COBRA premiums necessary to continue Executive’s and his
covered dependents’ health insurance coverage in effect for himself (and his covered dependents) on the termination date
until the earliest of: (i) twelve (12) months following the termination date (the “COBRA Severance Period”);
(ii) the date when Executive becomes eligible for substantially equivalent health insurance coverage in connection with new employment
or self-employment; or (iii) the date Executive ceases to be eligible for COBRA continuation coverage for any reason, including
plan termination (such period from the termination date through the earlier of (i)-(iii), (the “COBRA Payment Period”).  Notwithstanding
the foregoing, if at any time the Company determines that its payment of COBRA premiums on Executive’s behalf would result
in a violation of applicable law

 

    	 	6.	 

     

    

 

(including, but not limited
to, the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act),
then in lieu of paying COBRA premiums pursuant to this Section, the Company shall pay Executive on the last day of each remaining
month of the COBRA Payment Period, a fully taxable cash payment equal to the COBRA premium for such month, subject to applicable
tax withholding (such amount, the “Special Severance Payment”), for the remainder of the COBRA Payment
Period.  Nothing in this Agreement shall deprive Executive of his rights under COBRA or ERISA for benefits under plans
and policies arising under his employment by the Company.

 

(iv)        Notwithstanding
the terms of any equity plan or award agreement to the contrary, the time-based vesting conditions applicable to all of Executive’s
outstanding stock options and/or other equity awards subject to time-based vesting requirements as of Executive’s termination
date shall vest as follows: (A) if such termination occurs within two (2) months prior to or on the effective date of a Change
in Control, the time-based vesting restrictions shall accelerate and be deemed to be satisfied as of the date of Executive’s
termination, and (B) if such termination occurs within twelve (12) months following the effective date of a Change in Control,
in the event any surviving corporation or acquiring corporation assumes Executive’s stock options and/or other equity awards,
as applicable, or substitutes similar stock options or equity awards for Executive’s stock options and/or equity awards,
as applicable, in accordance with the terms of the Company’s equity incentive plans, the time-based vesting of all of such
stock options and/or equity awards (or any substitute stock options or equity awards), as applicable, shall be accelerated in full
as of the date of termination.  For the avoidance of doubt, the accelerated vesting provided under this Section 6.2(a)(iv)
shall not apply to any liquidity event or performance-based vesting conditions applicable to any of Executive’s outstanding
stock options and/or other equity awards as of the date of termination.

 

(b)           The
Change in Control Severance Benefits provided to Executive pursuant to this Section 6.2 are in lieu of, and not in addition
to, any benefits to which Executive may otherwise be entitled under any Company severance plan, policy or program, including but
not limited to the Severance Benefits described in Section 6.1(b).  For the avoidance of doubt, in no event shall
Executive be entitled to benefits under both Section 6.1(b) and this Section 6.2.  If Executive is eligible for benefits
under both Section 6.1(b) and this Section 6.2, or if Executive begins receiving benefits under Section 6.1(b) and later becomes
eligible for benefits under Section 6.2, Executive shall receive the benefits set forth in this Section 6.2 and such benefits will
be reduced by any benefits previously provided to Executive under Section 6.1(b).

 

(c)           Any
damages caused by the termination of Executive’s employment without Cause or for Good Reason following a Change in Control
would be difficult to ascertain; therefore, the Change in Control Severance Benefits for which Executive is eligible pursuant to
Section 6.2(a) above in exchange for the Release is agreed to by the parties as liquidated damages, to serve as full compensation,
and not a penalty.

 

6.3          Termination
by the Company for Cause.

 

(a)           The
Company shall have the right to terminate Executive's employment with the Company at any time, in accordance with Section 6.6,
for Cause by giving notice as described in Section 7.1 of this Agreement.  In the event Executive's

 

    	 	7.	 

     

    

 

employment is terminated
at any time for Cause, Executive will not receive Severance Benefits, Change in Control Severance Benefits, or any other severance
compensation or benefits, except that, pursuant to the Company's standard payroll policies, the Company shall pay to Executive
the Accrued Obligations.

 

(b)           "Cause"
for  termination  shall  mean  that  the  Company  has
determined in its sole discretion that Executive has engaged in any of the following: (i) a material breach of any covenant or
condition under this Agreement or any other agreement between the parties; (ii) any act constituting dishonesty, fraud, immoral
or disreputable conduct; (iii) any conduct which constitutes a felony under applicable law; (iv) material violation of any Company
policy or any act of misconduct; (v) refusal to follow or implement a clear and reasonable directive of Company; (vi) negligence
or incompetence in the performance of Executive’s  duties or failure to perform such duties in a manner satisfactory
to the Company after the expiration of ten (10) days without cure after written notice of such failure; or (vii) breach of fiduciary
duty.

 

6.4          Resignation
by Executive.

 

(a)           Executive
may resign from Executive’s employment with the Company at any time, in accordance with Section 6.6, by giving notice
as described in Section 7.1.

 

(b)           In
the event Executive resigns from Executive’s employment with the Company for any reason other than Good Reason in accordance
with Sections 6.1 or 6.2, Executive will not receive Severance Benefits, Change in Control Severance Benefits, or any other
severance compensation or benefits, except that, pursuant to the Company’s standard payroll policies, the Company shall pay
to Executive the Accrued Obligations.

 

6.5          Termination
by Virtue of Death or Disability of Executive.

 

(a)           In
the event of Executive’s death while employed pursuant to this Agreement, all obligations of the parties hereunder shall
terminate immediately, in accordance with Section 6.6, and the Company shall, pursuant to the Company’s standard payroll
policies, pay to Executive’s legal representatives all Accrued Obligations.

 

(b)           Subject
to applicable state and federal law, the Company shall at all times have the right, upon written notice to Executive, and in accordance
with Section 6.6, to terminate this Agreement based on Executive’s Disability.  Termination by the Company
of Executive’s employment based on “Disability” shall mean termination because Executive is unable
due to a physical or mental condition to perform the essential functions of his position with or without reasonable accommodation
for 180 days in the aggregate during any twelve (12) month period or based on the written certification by two licensed physicians
of the likely continuation of such condition for such period.  This definition shall be interpreted and applied consistent
with the Americans with Disabilities Act, the Family and Medical Leave Act, and other applicable law.  In the event Executive’s
employment is terminated based on Executive’s Disability, Executive will not receive Severance Benefits, Change in Control
Severance Benefits,

 

    	 	8.	 

     

    

 

or any other severance
compensation or benefit, except that, pursuant to the Company’s standard payroll policies, the Company shall pay to Executive
the Accrued Obligations.

 

6.6          Notice;
Effective Date of Termination.  

 

(a)           Termination
of Executive’s employment pursuant to this Agreement shall be effective on the earliest of:

 

(i)          immediately
after the Company gives notice to Executive of Executive’s termination, with or without Cause, unless pursuant to Section
6.3(b)(vi) in which case ten (10) days after notice if not cured or unless the Company specifies a later date, in which case, termination
shall be effective as of such later date;

 

(ii)         immediately
upon the Executive’s  death;

 

(iii)        ten
(10) days after the Company gives notice to Executive of Executive’s  termination on account of Executive’s
Disability, unless the Company specifies a later date, in which case, termination shall be effective as of such later date, provided
that Executive has not returned to the full time performance of Executive’s duties prior to such date;

 

(iv)        ten
(10) days after the Executive gives written notice to the Company of Executive’s resignation, provided that the Company
may set a termination date at any time between the date of notice and the date of resignation, in which case the Executive’s  resignation
shall be effective as of such other date.  Executive will receive compensation through any required notice period; or

 

(v)         for
a termination for Good Reason, immediately upon Executive’s full satisfaction of the requirements of Section 6.1(g).

 

(b)           In
the event notice of a termination under subsections (a)(i) or (iii) is given orally, at the other party’s request, the party
giving notice must provide written confirmation of such notice within five (5) business days of the request in compliance with
the requirement of Section 7.1 below.  In the event of a termination for Cause, written confirmation shall specify
the subsection(s) of the definition of Cause relied on to support the decision to terminate.

 

6.7          Cooperation
with Company after Termination of Employment.  Following termination of Executive’s employment for any reason,
Executive agrees to cooperate fully with the Company in connection with its actual or contemplated defense, prosecution, or investigation
of any claims or demands by or against third parties, or other matters arising from events, acts, or failures to act that occurred
during the period of Executive’s employment by the Company.  Such cooperation includes, without limitation, making
Executive available to the Company upon reasonable notice, without subpoena, to provide complete, truthful and accurate information
in witness interviews, depositions and trial testimony.  In addition, for twelve (12) months after Executive’s
employment with the Company ends for any reason, Executive agrees to cooperate fully with the Company in all matters relating to
the transition of Executive’s work and responsibilities on behalf of the Company, including, but not limited to, any present,
prior or subsequent relationships and the orderly transfer of any such work and institutional knowledge to

 

    	 	9.	 

     

    

 

such other persons as
may be designated by the Company.  The Company will reimburse Executive for reasonable out-of-pocket expenses Executive
incurs in connection with any such cooperation (excluding forgone wages, salary, or other compensation) and will make reasonable
efforts to accommodate Executive’s scheduling needs.  

 

6.8          Application
of Section 409A.  It is intended that all of the severance payments payable under this Agreement satisfy, to the
greatest extent possible, the exemptions from the application of Section 409A of the Code and the regulations and other guidance
thereunder and any state law of similar effect (collectively, “Section 409A”) provided under Treasury
Regulations Sections 1.409A-1(b)(4) and 1.409A-1(b)(9), and this Agreement will be construed in a manner that complies with Section
409A.  If not so exempt, this Agreement (and any definitions hereunder) will be construed in a manner that complies with
Section 409A, and incorporates by reference all required definitions and payment terms.  No severance payments will be
made under this Agreement unless Executive’s termination of employment constitutes a “separation from service”
(as defined under Treasury Regulation Section 1.409A-1(h)).  For purposes of Section 409A (including, without limitation,
for purposes of Treasury Regulations Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments
under this Agreement (whether severance payments or otherwise) shall be treated as a right to receive a series of separate payments
and, accordingly, each installment payment hereunder shall at all times be considered a separate and distinct payment.  If
the Company determines that the severance benefits provided under this Agreement constitutes “deferred compensation”
under Section 409A and if Executive is a “specified employee” of the Company, as such term is defined in Section 409A(a)(2)(B)(i)
of the Code at the time of Executive’s Separation from Service, then, solely to the extent necessary to avoid the incurrence
of the adverse personal tax consequences under Section 409A, the timing of the Severance will be delayed as follows:  on
the earlier to occur of (a) the date that is six months and one day after Executive’s Separation from Service, and (b) the
date of Executive’s death (such earlier date, the “Delayed Initial Payment Date”), the Company
will (i) pay to Executive a lump sum amount equal to the sum of the severance benefits that Executive would otherwise have received
through the Delayed Initial Payment Date if the commencement of the payment of the severance benefits had not been delayed pursuant
to this Section 6.8 and (ii) commence paying the balance of the severance benefits in accordance with the applicable payment schedule
set forth in Section 6.  No interest shall be due on any amounts deferred pursuant to this Section 6.8.  To
the extent that any Severance Benefits are deferred compensation under Section 409A of the Code, and are not otherwise exempt from
the application of Section 409A, then, if the period during which Executive may consider and sign the Release spans two calendar
years, the payment of any such Severance Benefit will not be made or begin until the later calendar year.

 

6.9          Section
280G. Notwithstanding any other provision of this Agreement to the contrary, if payments made or benefits provided pursuant
to this Agreement or otherwise from the Company or any person or entity are considered “parachute payments” under Section
280G of the Code, then such parachute payments will be limited to the greatest amount that may be paid to Executive under Section
280G of the Code without causing any loss of deduction to the Company Group under such section, but only if, by reason of such
reduction, the net after tax benefit to Executive will exceed the net after tax benefit if such reduction were not made.  “Net
after tax benefit” for purposes of this Agreement will mean the sum of (i) the total amounts payable to the Executive
under this Agreement, plus (ii) all other payments and benefits which

 

    	 	10.	 

     

    

 

the Executive receives
or then is entitled to receive from the Company or otherwise  that would constitute a “parachute payment”
within the meaning of Section 280G of the Code, less (iii) the amount of federal and state income taxes payable with respect to
the foregoing calculated at the maximum marginal income tax rate for each year in which the foregoing will be paid to Executive
(based upon the rate in effect for such year as set forth in the Code at the time of termination of Executive’s employment),
less (iv) the amount of excise taxes imposed with respect to the payments and benefits described in (i) and (ii) above by Section
4999 of the Code.  The determination as to whether and to what extent payments are required to be reduced in accordance
with this Section 6.9 will be made at the Company’s expense by a nationally recognized certified public accounting firm as
may be designated by the Company prior to a change in control (the “Accounting Firm”).  In
the event of any mistaken underpayment or overpayment under this Agreement, as determined by the Accounting Firm, the amount of
such underpayment or overpayment will forthwith be paid to Executive or refunded to the Company, as the case may be, with interest
at one hundred twenty (120%) of the applicable Federal rate provided for in Section 7872(f)(2) of the Code.  Any reduction
in payments required by this Section 6.9 will occur in the following order:  (1) any cash severance, (2) any other cash
amount payable to Executive, (3) any benefit valued as a “parachute payment,” (4) the acceleration of vesting of any
equity awards that are options, and (5) the acceleration of vesting of any other equity awards.  Within any such category
of payments and benefits, a reduction will occur first with respect to amounts that are not “deferred compensation”
within the meaning of Section 409A and then with respect to amounts that are.  In the event that acceleration of compensation
from equity awards is to be reduced, such acceleration of vesting will be canceled, subject to the immediately preceding sentence,
in the reverse order of the date of grant.

 

7.           General
Provisions.

 

7.1          Notices.  Any
notices required hereunder to be in writing shall be deemed effectively given:  (a) upon personal delivery to the party
to be notified, (b) when sent by electronic mail or confirmed facsimile if sent during normal business hours of the recipient,
and if not, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt
requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized overnight courier, specifying next day
delivery, with written verification of receipt.  All communications shall be sent to the Company at its primary office
location and to Executive at either Executive’s address as listed on the Company payroll, or Executive’s Company-issued
email address, or at such other address as the Company or Executive may designate by ten (10) days advance written notice to the
other.

 

7.2          Severability.  Whenever
possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law
or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or any other jurisdiction,
but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions
had never been contained herein.

 

    	 	11.	 

     

    

 

7.3          Survival.  Provisions
of this Agreement which by their terms must survive the termination of this Agreement in order to effectuate the intent of the
parties will survive any such termination for such period as may be appropriate under the circumstances.

 

7.4          Waiver.  If
either party should waive any breach of any provisions of this Agreement, it shall not thereby be deemed to have waived any preceding
or succeeding breach of the same or any other provision of this Agreement.

 

7.5          Complete
Agreement.  This Agreement constitutes the entire agreement between Executive and the Company with regard to the
subject matter hereof.  This Agreement is the complete, final, and exclusive embodiment of their agreement with regard
to this subject matter and supersedes any prior oral discussions or written communications and agreements, including the Prior
Agreement.  This Agreement is entered into without reliance on any promise or representation other than those expressly
contained herein, and it cannot be modified or amended except in writing signed by Executive and an authorized officer of the Company.  The
parties have entered into a separate Proprietary Information Agreement and have or may enter into separate agreements related to
equity.  These separate agreements govern other aspects of the relationship between the parties, have or may have provisions
that survive termination of Executive’s employment under this Agreement, may be amended or superseded by the parties without
regard to this Agreement and are enforceable according to their terms without regard to the enforcement provision of this Agreement.

 

7.6          Counterparts.  This
Agreement may be executed in separate counterparts, any one of which need not contain signatures of more than one party, but all
of which taken together will constitute one and the same Agreement.  The parties agree that facsimile and scanned image
copies of signatures will suffice as original signatures.

 

7.7          Withholding
Taxes.  The Company will be entitled to withhold from any payment due to Executive hereunder any amounts required
to be withheld by applicable tax laws or regulations.

 

7.8          Headings.  The
headings of the sections hereof are inserted for convenience only and shall not be deemed to constitute a part hereof nor to affect
the meaning thereof.

 

7.9          Successors
and Assigns.  The Company shall assign this Agreement and its rights and obligations hereunder in whole, but not
in part, to any Company or other entity with or into which the Company may hereafter merge or consolidate or to which the Company
may transfer all or substantially all of its assets, if in any such case said Company or other entity shall by operation of law
or expressly in writing assume all obligations of the Company hereunder as fully as if it had been originally made a party hereto,
but may not otherwise assign this Agreement or its rights and obligations hereunder.  Executive may not assign or transfer
this Agreement or any rights or obligations hereunder, other than to his estate upon his death.

 

7.10        Choice
of Law.  All questions concerning the construction, validity and interpretation of this Agreement will be governed
by the laws of the State of New Jersey.

 

    	 	12.	 

     

    

 

7.11        Dispute
Resolution.  The parties recognize that litigation in federal or state courts or before federal or state administrative
agencies of disputes arising out of the Executive’s employment with the Company or out of this Agreement, or the Executive’s
termination of employment or termination of this Agreement, may not be in the best interests of either the Executive or the Company,
and may result in unnecessary costs, delays, complexities, and uncertainty.  The parties agree that any dispute between
the parties arising out of or relating to the negotiation, execution, performance or termination of this Agreement or the Executive’s  employment,
including, but not limited to, any claim arising out of this Agreement, claims under Title VII of the Civil Rights Act of 1964,
as amended, the Civil Rights Act of 1991, the Age Discrimination in Employment Act of 1967, the Americans with Disabilities Act
of 1990, Section 1981 of the Civil Rights Act of 1966, as amended, the Family Medical Leave Act, the Executive Retirement Income
Security Act, and any similar federal, state or local law, statute, regulation, or any common law doctrine, whether that dispute
arises during or after employment, shall be settled by binding arbitration in accordance with the National Rules for the Resolution
of Employment Disputes of the American Arbitration Association; provided however, that this dispute resolution provision
shall not apply to any separate agreements between the parties that do not themselves specify arbitration as an exclusive remedy.
The location for the arbitration shall be the Princeton/Trenton, New Jersey area.  Any award made by such panel
shall be final, binding and conclusive on the parties for all purposes, and judgment upon the award rendered by the arbitrators
may be entered in any court having jurisdiction thereof. The arbitrators’ fees and expenses and all administrative fees and
expenses associated with the filing of the arbitration shall be borne by the Company; provided however, that at the
Executive’s  option, Executive may voluntarily pay up to one-half the costs and fees. The parties acknowledge and
agree that their obligations to arbitrate under this Section survive the termination of this Agreement and continue after the termination
of the employment relationship between Executive and the Company. The parties each further agree that the arbitration provisions
of this Agreement shall provide each party with its exclusive remedy, and each party expressly waives any right it might
have to seek redress in any other forum, except as otherwise expressly provided in this Agreement.  By election arbitration
as the means for final settlement of all claims, the parties hereby waive their respective rights to, and agree not to, sue
each other in any action in a Federal, State or local court with respect to such claims, but may seek to enforce in court an arbitration
award rendered pursuant to this Agreement.  The parties specifically agree to waive their respective rights to a trial
by jury, and further agree that no demand, request or motion will be made for trial by jury. 

 

[signatures
to follow on next page]

 

    	 	13.	 

     

    

 

In
Witness Whereof, the parties have duly executed this Agreement as of the date first above written.

 

	 	Oncobiologics, Inc.
	 	 	 
	 	By:	/s/ Pankaj Mohan, Ph.D.
	 	 	Name: Pankaj Mohan, Ph.D.
	 	 	Title: President and Chief Executive Officer
	 	 	 
	 	Executive
	 	 
	 	/s/ Lawrence A. Kenyon
	 	Lawrence A. KenyonExhibit 10.29

 

Amended and Restated

Performance Stock
Unit Agreement

 

	Participant: 	 

 

	Grant Date: 	 

 

	Date of Hire: 	 

 

	Number of Units: 	 

 

	Base Price: 	 

 

	Oncobiologics Serial Number: 	 

 

     

     

    

 

Amended and Restated

Performance Stock Units (PSUs)

 

THIS AMENDED AND RESTATED
PERFORMANCE STOCK UNIT AGREEMENT (the “Amended and Restated Agreement”), dated as of _________________ (the “Effective
Date”), is between Oncobiologics, Inc., a Delaware corporation (the “Company”), and _____________________________
(the “Participant”).

 

WHEREAS, the Company
previously granted to the Participant Performance Stock Units  (“PSUs”) pursuant to Article IX of
the  Oncobiologics, Inc. 2011 Stock Incentive Plan (the “Plan”) as provided in the Performance Stock
Unit Agreement dated [__________] (the “Prior Agreement”);

 

WHEREAS, the Company
and the Participant desire to make certain changes to the PSUs granted under the Plan and Prior Agreement pursuant to the terms
of this Amended and Restated Agreement, which shall supersede and replace the Prior Agreement in its entirety.

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants hereinafter set forth and for other good and valuable consideration, receipt
of which is hereby acknowledged, the parties agree as follows:

 

1.           Definitions;
Receipt of Plan.  For purposes of this Amended and Restated Agreement, the definitions of terms contained in
the Plan hereby are incorporated by reference, except to the extent that any term is specifically defined in this Amended and Restated
Agreement.  The Participant hereby acknowledges receipt of a copy of the Plan.

 

2.           PSUs,
Term, and Vesting.

 

(a)          Grant
of PSUs.  The Company granted PSUs with respect to [_____________] shares of the Company’s common stock (“Common
Stock”) to the Participant on [____________] (the “Grant Date”).  The price (the “Base
Price”) to be used as the basis for determining the PSU Value (as defined below) upon exercise of each PSU is [_______________],
which was the fair market value of one share of the Company’s common stock on the Grant Date.  

 

(b)          Vesting
and Expiration of PSUs.  Subject to the provisions of the Plan and this Amended and Restated Agreement, the PSUs
and shall become exercisable (vest) on the following dates (each such date, a “Vesting Date”), subject to the
terms of Section 2(c):

 

i)         50%
(1/2) on [__________________]; and

ii)        50%
(1/2) on [__________________].

 

    	 	 	Page 2 of 9

     

    

 

The Participant must remain employed by
the Company or an Affiliate through the applicable Vesting Date in order for the PSUs to vest on such date with the exception of
provisions per Section 3(a).  [Notwithstanding the foregoing, 100% of the PSUs shall vest upon the consummation of a
Change in Control, subject to the Participant’s continuous employment with the Company through the effective date of the
Change in Control.]  The PSUs will expire on the tenth anniversary of the Grant Date (the “Term”).  

 

(c)           Exercisability.  Notwithstanding
Section 2(b) of this Amended and Restated Agreement, the vested PSUs shall not become exercisable until the occurrence of any of
the following:

 

		·	A Change in Control of the Company or initial public offering of the Company’s Common Stock;

		·	A Fair Market Value of at least $400 Million for the Company has been achieved and subject to discretion
of the Board.

 

Following the occurrence
of one of the foregoing events, the vested PSUs will remain exercisable for the remainder of the Term, unless terminated in accordance
with the terms of Section 3(a).  In no event may the PSUs be exercised following the last day of the Term.  The
PSUs shall be exercisable during the Participant’s lifetime only by the Participant or his or her Representative, and after
the Participant’s death only by a Representative.  The PSUs may only be exercised by the delivery to the Company
of a properly completed written notice, in form satisfactory to the Company, which shall specify the number of shares of Common
Stock with respect to which the PSUs shall be exercised.

 

(d)           PSU
Value.  The amount to be paid upon exercise of the PSUs (the “PSU Value”) will be determined by
calculating (i) the difference between the Fair Market Value of a share of Common Stock on the date of exercise and the Base Price;
(ii) multiplied by the number of PSUs exercised.  The PSU Value is subject to applicable tax withholding in accordance
with applicable law.  At the discretion of the Company, the PSU Value may be distributed in cash or settled in shares
of Common Stock of the Company.  The number of shares of Common Stock that may be delivered upon exercise will be determined
by dividing the PSU Value by the Fair Market Value of a share of Common Stock on the date of exercise, rounded down to the nearest
whole share.

 

(e)           Accelerated
Vesting Upon a Change in Control.  If a Change in Control occurs during the Term of the PSUs and the Participant’s
employment is terminated by the Company or an Affiliate other than for Cause as a result of the Change in Control, then any unvested
PSU will become immediately vested in full upon such termination date.

 

3.           Terms
of PSUs.

 

(a)           Termination
of Employment prior to Vesting.  If prior to a Vesting Date, the Participant incurs a Termination of Employment for
any reason other than death, Disability or Retirement, the unvested PSUs shall be forfeited and terminate as of such date, and
the Participant shall have no interest in the unvested PSUs.  If prior to a Vesting Date a Participant has a Termination
of Employment due to death, Disability or Retirement, the PSUs that have not

 

    	 	 	Page 3 of 9

     

    

 

vested as of the effective
date of Termination of Employment shall vest on the earlier of (1) the first anniversary of such Termination of Employment or (2)
the expiration of the remaining vesting period, provided such dates occur prior to the end of the Term.  In no event
will such PSUs remain outstanding following the end of the Term.

 

(b)           Non-Assignability.  The
PSUs are personal to the Participant and are not transferable other than by will or the laws of descent and distribution.  

 

(c)           Changes
in the Company’s Capital Structure.  The existence of the PSUs will not affect in any way the right or authority
of the Company or its shareholders to make or authorize (i) any or all adjustments, recapitalizations, reorganizations or other
changes in the Company’s capital structure or its business; (ii) any merger or consolidation of the Company’s capital
structure or its business; (iii) any merger or consolidation of the Company; (iv) any issue of bonds, debentures, preferred or
prior preference stock ahead of or affecting the Common Stock or the rights thereof; (v) the dissolution or liquidation of the
Company; (vi) any sale or transfer of all or any part of its assets or business; or (g) any other corporate act or proceeding.  In
the event of a Change in Control or other corporate restructuring, the Participant shall have such rights, and the Committee shall
take such actions, as provided in the Plan.

 

(d)           Requirements
of Law; Registration Requirements.  In no event may the Participant exercise the PSUs unless the shares of Common
Stock issuable upon exercise are then registered under the Securities Act or, if not registered, the Company has determined that
the exercise and the issuance of the shares would be exempt from the registration requirements of the Securities Act.  The
Company shall not be required to issue any shares of Common Stock under the PSUs if the issuance of such shares shall constitute
a violation of any provision of any law or regulation of any governmental authority.  

 

(e)           Market
Stand-Off Agreement. By exercising the PSUs, the Participant agrees that the Participant will not sell, dispose of, transfer,
make any short sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic
effect as a sale with respect to any shares of Common Stock or other securities of the Company held by the Participant, for a period
of one hundred eighty (180) days following the effective date of a registration statement of the Company filed under the Securities
Act or such longer period as the underwriters or the Company will request to facilitate compliance with FINRA Rule 2711 or NYSE
Member Rule 472 or any successor or similar rules or regulation (the “Lock-Up Period”); provided, however, that
nothing contained in this section will prevent the exercise of a repurchase option, if any, in favor of the Company during the
Lock-Up Period.  The Participant further agrees to execute and deliver such other agreements as may be reasonably requested
by the Company or the underwriters that are consistent with the foregoing or that are necessary to give further effect thereto.  In
order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the shares of Common
Stock that may be issued upon exercise of the PSUs until the end of such period.  The Participant also agrees that any
transferee of any shares of Common Stock (or other securities) of the Company held by the Participant will be bound by this Section
3(e).  The underwriters of the Company’s stock are intended third party beneficiaries of this Section 3(e) and
will have the right, power and authority to enforce the provisions hereof as though they were a party hereto.

 

    	 	 	Page 4 of 9

     

    

 

(f)           Miscellaneous.  The
contents of this Amended and Restated Agreement are subject in all respects to the terms and conditions of the Plan, which are
controlling.  The interpretation and construction by the Board and/or the Committee of any provision of the Plan or this
Amended and Restated Agreement shall be final and conclusive upon the Participant, the Participant’s estate, executor, administrator,
beneficiaries, personal representative and guardian and the Company, its Affiliates and their successors and assigns.

 

The grant of the PSUs
is discretionary and will not be considered to be an employment contract or a part of the Participant’s terms and conditions
of employment or salary or compensation.  The Participant’s acceptance of this grant constitutes his or her consent
to the transfer of data and information concerning or arising out of this grant to the Company, its Affiliates and to entities
engaged by the Company to provide services in connection with this grant from non-U.S. entities related to the Company and its
Affiliates for purposes of any applicable privacy, information or data protection laws and regulations.

 

Any amendment to the
Plan shall be deemed to be an amendment to this Amended and Restated Agreement to the extent that the amendment is applicable hereto.  The
terms and conditions of this Amended and Restated Agreement may not be modified, amended or waived, except by an instrument in
writing signed by a duly authorized executive officer at the Company.  Notwithstanding the foregoing, no amendment shall
adversely affect the Participant’s rights under this Amended and Restated Agreement without his or her consent.

 

(g)           Compliance
with Section 409A of the Code.  To the extent applicable, it is intended that this Amended and Restated Agreement
and the Plan comply with the provisions of Section 409A of the Code, so that the income inclusion provisions of Section 409A(a)(1)
of the Code do not apply to the Participant.  This Amended and Restated Agreement and the Plan shall be administered
in a manner consistent with this intent, and any provision that would cause this Amended and Restated Agreement or the Plan to
fail to satisfy Section 409A of the Code shall have no force and effect until amended to comply with Section 409A of the Code (which
amendment may be retroactive to the extent permitted by Section 409A of the Code and may be made by the Company without your consent).  Reference
to Section 409A of the Code will also include any proposed, temporary or final regulations, or any other guidance, promulgated
with respect to such Section by the U.S. Department of the Treasury or the Internal Revenue Service.

 

4.           Payment
of Withholding Taxes.  If the Company or an Affiliate is obligated to withhold an amount on account of any tax
imposed as a result of the exercise of PSUs or the release of any restrictions or limitations in respect of PSUs, the Participant
shall be required to pay such amount to the Company and its Affiliates, as provided in the Plan and this Section 4.  The
Participant acknowledges and agrees that he or she is responsible for the tax consequences associated with the grant of the PSUs
and their exercise.  

 

(a)           At
the time the Participant exercises the PSUs, in whole or in part, and at any time thereafter as required by the Company, the Participant
hereby authorizes withholding from payroll and any other amounts payable to the Participant, and otherwise agrees to make adequate
provision for (including by means of a “same day sale” pursuant to a program developed under Regulation T as promulgated
by the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and
foreign tax

 

    	 	 	Page 5 of 9

     

    

 

withholding obligations
of the Company or any Affiliate, if any, which arise in connection with the exercise of the PSUs.  

 

(b)           Upon
the Participant’s request and subject to approval by the Company, and compliance with any applicable legal conditions or
restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to the Participant upon the
exercise of the PSUs a number of whole shares of Common Stock having a Fair Market Value, determined by the Company as of the date
of exercise, not in excess of the minimum amount of tax required to be withheld by law (or such lower amount as may be necessary
to avoid classification of your option as a liability for financial accounting purposes).  Any adverse consequences to
the Participant arising in connection with such share withholding procedure shall be the Participant’s sole responsibility.

 

(c)           The
Participant may not exercise the PSUs unless the tax withholding obligations of the Company and/or any Affiliate are satisfied.  Accordingly,
the Participant may not be able to exercise the PSUs when desired even though the PSUs are vested, and the Company will have no
obligation to issue a certificate for such shares of Common Stock or release such shares of Common Stock from any escrow provided
for herein, if applicable, unless such obligations are satisfied.

 

5.           Plan.  Notwithstanding
any other provision of this Amended and Restated Agreement, the PSUs are subject to the Plan, as in effect on the date hereof,
and is subject to all the terms and conditions thereof, as amended from time to time.  The interpretation and construction
by the Committee of the Plan, this Amended and Restated Agreement, and such rules and regulations as may be adopted by the Committee
for the purpose of administering the Plan, shall be final and binding upon the Participant.

 

6.           No
Shareholder Rights.  Until the PSUs shall have been exercised and any shares of Common Stock issuable upon exercise
have been recorded as issued by the Company’s official shareholder records, no person or entity shall be entitled to vote,
receive dividends or be deemed for any purpose the holder of any shares of Common Stock subject to the PSUs, and adjustments for
dividends or otherwise shall be made only if the record date is after both the date such shares are recorded and the date of exercise
and without duplication or any adjustment.

 

7.           No
Employment Rights.  No provision of this Amended and Restated Agreement or the PSUs or the shares of Common Stock
issuable hereunder shall give the Participant any right to continue in the employ of the Company, any Affiliate or any other entity,
create any inference as to the length of employment of the Participant, affect the right of the Company, any Affiliate or any other
entity to terminate the employment of the Participant, with or without Cause, or give the Participant any right to participate
in any employee welfare or benefit plan or other program (other than the Plan) of the Company, any Affiliate or any other entity.

 

8.           No
Disclosure Rights.  The Company shall have no duty or obligation to affirmatively disclose to the Participant
or a Representative, and the Participant or Representative shall have no right to be advised of, any material information regarding
the Company or an Affiliate at any time prior to, upon or in connection with the issuance of the PSUs or shares of Common Stock
subject to the PSUs.

 

    	 	 	Page 6 of 9

     

    

 

9.           Confidential
Information and Noncompetition.  The Participant agrees, as consideration for the Award of PSUs hereunder, to
abide by the terms and conditions of any employment agreement or covenant regarding confidential information or noncompetition,
as well as any agreement of covenant not to solicit the customers, suppliers or employees of the Company or an Affiliate.

 

10.          Governing
Law.  This Amended and Restated Agreement and the Award of PSUs hereunder shall be governed by, and construed
and enforced in accordance with, the laws of the State of New Jersey (other than its laws respecting choice of law).

 

11.          Entire
Agreement.  Effective as of the Effective Date, this Amended and Restated Agreement supersedes and replaces in
its entirety the Prior Agreement and the Prior Agreement is no longer in force or effect.  This Amended and Restated
Agreement, together with the Plan, constitutes the entire obligation of the parties hereto with respect to the subject matter hereof
and supersedes any agreements or prior expressions of intent or understanding with respect to this transaction.

 

12.          Amendment.  Any
amendment to this Amended and Restated Agreement shall be in writing and signed on behalf of the Company.

 

13.          Waiver;
Cumulative Rights.  The failure or delay of either party to require performance by the other party of any provision
hereof shall not affect its right to require performance of such provision unless and until such performance has been waived in
writing.  Each and every right hereunder is cumulative and may be exercised in part or in whole from time to time.

 

14.          Counterparts.  This
Amended and Restated Agreement may be signed in two (2) counterparts, each of which shall be an original, but both of which shall
constitute but one and the same instrument.

 

15.          Notices.  Any
notice which either party hereto may be required or permitted to give the other shall be in writing and may be delivered personally
or by mail, postage prepaid, addressed to the Secretary of the Company, at its then corporate headquarters, and the Participant
at his or her address shown on the Company’s payroll records, or to such other address as the Participant, by notice to the
Company, may designate in writing from time to time.

 

16.          Headings.  The
headings contained in this Amended and Restated Agreement are for reference purposes only and shall not affect the meaning or interpretation
of this Amended and Restated Agreement.

 

17.          Severability.  If
any provision of this Amended and Restated Agreement shall for any reason be held to be invalid or unenforceable, such invalidity
or unenforceability shall not affect any other provision hereof, and this Amended and Restated Agreement shall be construed as
if such invalid or unenforceable provision were omitted.

 

18.          Successors
and Assigns.  This Amended and Restated Agreement shall inure to the benefit of and be binding upon each successor
and assign of the Company.  All obligations imposed upon the Participant or a Representative, and all rights granted
to the Company

 

    	 	 	Page 7 of 9

     

    

 

hereunder, shall be binding
upon the Participant’s or the Representative’s heirs, legal representatives and successors.

 

19.          Tax
Consequences.  Neither the Company nor any Affiliate shall be liable or responsible in any way for the tax consequences
relating to the Award of PSUs or the lapse of the restrictions hereunder.  The Participant agrees to determine and be
responsible for any and all tax consequences to himself or herself relating to the Award of PSUs.

 

[signature page follows]

 

    	 	 	Page 8 of 9

     

    

 

IN WITNESS WHEREOF,
the Company has caused this Amended and Restated Agreement to be duly executed by an officer thereunto duly authorized, and the
Participant has signed this Amended and Restated Agreement, all as of the day and year first above written.

 

	 	ONCOBIOLOGICS, INC	 
	 	 	 	 
	 	By:	 	 	 
	 	 	 	 
	 	Name:	Pankaj Mohan, PhD MBA	 
	 	 	 	 
	 	Title:	Founder & CEO	 
	 	 	 	 
	 	Date:	 	 
	 	 	 	 
	 	PARTICIPANT:	 
	 	 	 	 
	 	By:	 	 	 
	 	 	(signature)	 
	 	 	 	 
	 	Name:	 	 
	 	 	 	 
	 	SSN:	 	 
	 	 	 	 
	 	Date:	 	 

 

    	 	 	Page 9 of 9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00257-of-00352.parquet"}]]